Policy, economics and countermeasures
著者
書誌事項
Policy, economics and countermeasures
（Counterfeit medicines, v. 1）
ILM, 2012
大学図書館所蔵 件 / 全1件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
Includes bibliographical references and index
内容説明・目次
内容説明
Although there is some debate about the extent of counterfeits in the world's pharmaceutical supply chain, it is undeniable that counterfeit and substandard medicines are a growing and dangerous business. They can cause major moral, reputational and financial damage to pharmaceutical manufacturers, as well as untold harm to patients who are deceived by the fake version of their medication. This book provides a concise account of the history, policy and law, and financial and economic aspects surrounding pharmaceutical product counterfeiting, as well as some of the countermeasures available to organisations. This valuable publication discusses the problems experienced in lesser developed countries, and reports the activities and findings of governments and agencies around the world. The growth in e-commerce means that the Internet has become the primary tool in the advertisement and sale of counterfeit pharmaceuticals by criminal organisations. The safety concerns regarding illicit online pharmacies are reviewed and an overview is given of the regulatory efforts attempting to stem their negative effects.
The book provides important information on creating an overall anti-counterfeit strategy and a review of current countermeasures, including authentication and tracing programmes. In addition, the book compares some of the problems that have been experienced with those encountered by other product areas in relation to counterfeiting. Important lessons have been learned by other industries, including fine art, wine, diamonds, currency and aeroplane parts. With the inclusion of economic and financial models and projections as well as real-life case studies, this book is essential reading for individuals and organisations affected by this complex issue.
目次
Chapter 1 The Background and History of Counterfeit Medicines Obinna Obi-Eyisi and Albert I. Wertheimer Chapter 2 The Current Policy and Law of Counterfeit Medicines: In Memoriam to Donald Eulette deKieffer, 1945 - 2011 Donald deKieffer and J. Kevin Horgan Chapter 3 The Financial and Economic Aspects of Counterfeit Medicines F. Ellen Loh Chapter 4 The Counterfeiting of Pharmaceutical Products in Lesser Developed Countries: A Case Study of Mexico Rafael Gual Cosio Chapter 5 The Fight Against Counterfeit and Substandard Pharmaceuticals by Governments, International Agencies and Professional Societies Anna Gu Chapter 6 International Politics Becomes Involved in the Fight Against Counterfeit Medicines Kawthar ElBishlawi Chapter 7 Addressing Illicit Online Pharmacies: Global Patient Safety and Regulatory Challenges Bryan A. Liang and Tim Mackey Chapter 8 Counterfeiting in Other Industries: Lessons for Pharmaceuticals Nazli Sencan Chapter 9 Overview of the Selection of Strategic Authentication and Tracing Programmes John Spink
「Nielsen BookData」 より
